Fosun Tourism travels back to home base with delisting plan
The resort operator is being absorbed back into the Fosun group via a buyout offer to minority shareholders, with a focus on China’s domestic travel market Key Takeaways: Fosun Tourism’s…
Bumpy ride for Fosun Tourism as bargain holidays on the rise
The Chinese owner of the Club Med chain and other travel brands is facing tighter tourism spending and could become a casualty of its parent’s debt problems Key Takeaways: Fosun…
Fosun Tourism’s post-Covid holiday fizzles
The resort unit of one of China’s leading conglomerates posted modest growth in the first quarter, as its broader outlook was clouded by debt issues at its parent Key Takeaways:…
Fosun International on cusp of new ‘asset-light’ era with latest sale
The conglomerate is selling its stake in multinational insurer Ageas, extending a slimming exercise touched off by a liquidity crisis in 2022 Key Takeaways: Fosun International’s total debt-to-capitalization ratio stood…
Fosun Tourism at crossroads as parent shops its two major assets
Fosun International is reportedly looking to sell some or all of its tourism unit’s Atlantis Sanya mega-resort, as well as a stake in the unit’s Club Med resort chain Key…
Is Fosun Set to Rise Again as China Reopens?
The debt-heavy conglomerate announced a fresh $1 billion in asset sales last week, as growing signs emerge that its looming debt crisis of 2022 may be recedingKey Takeaways:Fosun International announced…
Fosun Seeks Club Med Investors to Plug Its Own Financial Holes
The debt-plagued financial conglomerate is reportedly looking for a third party to buy some or all of its majority stake in Fosun Tourism, owner of the French resort chainKey Takeaways:Debt-strapped…
Recent Articles
Fosun Tourism travels back to home base with delisting plan
1992.HK
0656.HK
Fosun Tourism at crossroads as parent shops its two major assets
1992.HK
0656.HK
RELATED ARTICLES
-
Fosun moves on from debt crisis with renewed focus on tourism, healthcare
0656.HK - Huoli rides China travel boom to Hong Kong IPO
-
‘Revenge travel’ slowdown puts damper on Trip.com’s banner year
9961.HK
-
BRIEF: Fosun Tourism may have dropped into the red last year
1992.HK
-
After a failed Fosun buyout, what’s next for drug maker Henlius Biotech?
2696.HK
-
BRIEF: Fosun pledges 27% of Fosun Pharma’s A-shares
2196.HK 600196.SHG
-
Property crisis deepens with debt action against Sunac
1918.HK
